Table 4.
Functional status and quality of life during follow-up in nonagenarians who underwent TAVR.
| Variable | Baseline | 1–3 mo | 1 y |
|---|---|---|---|
| Functional status | |||
| 6-min walk test distance, m | 192 ± 84 (n = 96) | 259 ± 102∗ (n = 63) | 252 ± 97∗ (n = 56) |
| Quality of life | |||
| KCCQ score | 64 (52–73) (n = 109) |
79 (68–91)∗ (n = 74) |
81 (70–94)∗ (n = 53) |
| DASI score | 13 ± 7 (n = 131) | 16 ± 10∗ (n = 101) | 16 ± 9∗ (n = 108) |
| Euro Quality of Life - 5 Dimensions questionnaire | (n = 131) | (n = 103) | (n = 101) |
| Mobility ≥ 2 | 51 (39) | 46 (45) | 52 (52)∗ |
| Self-care ≥ 2 | 22 (17) | 18 (17) | 21 (21) |
| Activities ≥ 2 | 76 (58) | 44 (43)∗ | 42 (42)∗ |
| Pain ≥ 2 | 47 (36) | 39 (38) | 38 (38) |
| Anxiety ≥ 2 | 28 (21) | 26 (25) | 16 (16) |
| Health state scale, % | 63 ± 16 | 71 ± 15∗ | 74 ± 15∗ |
Values are mean ± standard deviation, median (25th-75th percentile), or EuroQoL-5D score (n).
DASI, Duke Activity Status Index; KCCQ, Kansas City Cardiomyopathy Questionnaire.
∗
Significant paired difference vs baseline, P < 0.05.